H.R. 6130119th Congress
ASAP Act
Progress
- Introduced
- In committee
- Passed one chamber Not yet
- Passed Congress Not yet
- Sent to President Not yet
- Became law Not yet
In plain language
Alzheimer's Screening and Prevention Act of 2025 or the ASAP Act
This bill provides for Medicare coverage of blood tests to screen for the early stages of Alzheimer’s disease or related dementias. Specifically, the bill provides for coverage of genomic sequencing blood or blood product tests, or other equivalent tests, that are approved by the Food and Drug Administration.
Summary by the Congressional Research Service, a nonpartisan office of the Library of Congress. Version summarized: Introduced in House.
Legislative history
-
House
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 0.
-
House
Committee Consideration and Mark-up Session Held
-
House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
Introduced in House